United Arab Emirates Medical QMS Software Market Size & Outlook, 2026-2034
United Arab Emirates Medical QMS Software Market Insights
- Based on Reed Intelligence findings, the United Arab Emirates Medical QMS Software Market reached USD 32.16 Million in 2025 and is estimated to attain USD 114.13 Million by 2034.
- From 2026 to 2034, the United Arab Emirates market is expected to grow at a steady CAGR of 15.08%.
- Within the By Solution Type category, Complaint Handling dominated in 2025 in terms of market size contribution.
- Over the forecast period, Non-conformances/ Corrective & Preventive is forecasted to deliver the fastest growth, positioning it as the most lucrative By Solution Type segment.
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- In 2025, United Arab Emirates represented 4.75% of the overall global Medical QMS Software Market size.
- United States is projected to lead the global Medical QMS Software Market size by 2034.
- Across Middle East and Africa, United Arab Emirates is anticipated to hold the dominant position in market size by 2034.
- Egypt is forecasted to expand at the fastest pace in Middle East and Africa, attaining USD 24.54 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 32.16 Million |
| Market Size In 2034 | USD 114.13 Million |
| Largest segment | Complaint Handling |
| Units | Revenue in USD Million |
| CAGR | 15.08% (2026-2034) |
| Segmnetation Covered | |
| By Solution Type |
|
| By Deployment Type |
|
| By End User |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United Arab Emirates Medical QMS Software Market By Solution Type 2026-2034 (USD Million)
| By Solution Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Complaint Handling | XX.x | XX.x | XX.x | 12.79 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Document Control | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Audit Management | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Non-conformances/ Corrective & Preventive | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Supplier Quality Management | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Others | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
United Arab Emirates Medical QMS Software Market By Deployment Type 2026-2034 (USD Million)
| By Deployment Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| On-premises | XX.x | XX.x | XX.x | 20.76 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Cloud-based | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
United Arab Emirates Medical QMS Software Market By End User 2026-2034 (USD Million)
| By End User | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SMEs | XX.x | XX.x | XX.x | 20.49 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Large Enterprises | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.